Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,941 | 672 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,996 | 181 | $0 (2024) |
| Amgen Inc. | $3,003 | 186 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $942.95 | 52 | $0 (2024) |
| PFIZER INC. | $899.97 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $702.54 | 43 | $0 (2024) |
| UCB, Inc. | $651.94 | 46 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $340.75 | 16 | $0 (2024) |
| Celgene Corporation | $239.90 | 17 | $0 (2019) |
| Mallinckrodt LLC | $171.56 | 10 | $0 (2018) |
| GENZYME CORPORATION | $158.28 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,132 | 101 | ABBVIE INC. ($887.16) |
| 2023 | $2,178 | 108 | AbbVie Inc. ($742.31) |
| 2022 | $1,889 | 101 | ABBVIE INC. ($687.26) |
| 2021 | $2,276 | 133 | AbbVie Inc. ($989.71) |
| 2020 | $1,278 | 73 | AbbVie Inc. ($507.01) |
| 2019 | $760.73 | 49 | Amgen Inc. ($198.26) |
| 2018 | $734.49 | 49 | Amgen Inc. ($355.15) |
| 2017 | $691.85 | 58 | Amgen Inc. ($367.75) |
All Payment Transactions
672 individual payment records from CMS Open Payments — Page 2 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/03/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/28/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Dermatology | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Inflammation | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.01 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 07/30/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Dermatology | ||||||
| 07/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Inflammation | ||||||
| 07/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.81 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Dermatology | ||||||
| 06/19/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.46 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 28 | 29 | $957.00 | $145.44 |
| 2022 | 2 | 301 | 391 | $19,011 | $4,008 |
| 2021 | 1 | 305 | 373 | $12,309 | $2,324 |
| 2020 | 2 | 189 | 218 | $11,919 | $3,337 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 28 | 29 | $957.00 | $145.44 | 15.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 289 | 379 | $12,507 | $2,255 | 18.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $6,504 | $1,753 | 27.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 305 | 373 | $12,309 | $2,324 | 18.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 21 | 21 | $5,418 | $2,085 | 38.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 168 | 197 | $6,501 | $1,253 | 19.3% |
About Dr. Jaime Castillo, M.D
Dr. Jaime Castillo, M.D is a Internal Medicine healthcare provider based in Houston, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538179536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaime Castillo, M.D has received a total of $11,941 in payments from pharmaceutical and medical device companies, with $2,132 received in 2024. These payments were reported across 672 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($11,941).
As a Medicare-enrolled provider, Castillo has provided services to 823 Medicare beneficiaries, totaling 1,011 services with total Medicare billing of $9,815. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Houston, MS
- Active Since 08/09/2006
- Last Updated 01/18/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1538179536
Products in Payments
- Enbrel (Biological) $2,859
- RINVOQ (Biological) $2,351
- ACTHAR (Biological) $1,115
- SKYRIZI (Biological) $703.21
- Cimzia (Drug) $618.13
- XELJANZ (Drug) $577.56
- COSENTYX (Biological) $398.83
- Otezla (Drug) $384.50
- RINVOQ (Drug) $370.80
- LUPKYNIS (Drug) $340.75
- COSENTYX (Drug) $282.53
- HUMIRA (Biological) $206.58
- KEVZARA (Biological) $158.28
- BENLYSTA (Biological) $152.82
- Humira (Biological) $145.12
- PURIFIED CORTROPHIN GEL (Drug) $101.36
- COLOGUARD DNA CAPTURE REAGENTS (Device) $93.30
- TREMFYA (Drug) $92.70
- REXULTI (Drug) $84.31
- CHANTIX (Drug) $63.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947